MENU
+Compare
COR
Stock ticker: NYSE
AS OF
Jun 25, 04:59 PM (EDT)
Price
$292.31
Change
-$1.81 (-0.62%)
Capitalization
48.42B

COR stock forecast, quote, news & analysis

Cencora is one of three domestic leading pharmaceutical wholesalers... Show more

COR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for COR with price predictions
Jun 24, 2025

COR's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for COR turned positive on June 13, 2025. Looking at past instances where COR's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 12, 2025. You may want to consider a long position or call options on COR as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

COR moved above its 50-day moving average on June 11, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where COR advanced for three days, in of 375 cases, the price rose further within the following month. The odds of a continued upward trend are .

COR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 305 cases where COR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where COR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. COR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: COR's P/B Ratio (53.191) is very high in comparison to the industry average of (7.892). P/E Ratio (26.471) is within average values for comparable stocks, (29.460). Projected Growth (PEG Ratio) (2.774) is also within normal values, averaging (4.521). Dividend Yield (0.008) settles around the average of (0.032) among similar stocks. P/S Ratio (0.182) is also within normal values, averaging (35.215).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
published Dividends

COR paid dividends on June 02, 2025

Cencora COR Stock Dividends
А dividend of $0.55 per share was paid with a record date of June 02, 2025, and an ex-dividend date of May 16, 2025. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are McKesson Corp (NYSE:MCK).

Industry description

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

Market Cap

The average market capitalization across the Medical Distributors Industry is 10.22B. The market cap for tickers in the group ranges from 494.39K to 70.55B. MCK holds the highest valuation in this group at 70.55B. The lowest valued company is SNYR at 494.39K.

High and low price notable news

The average weekly price growth across all stocks in the Medical Distributors Industry was -0%. For the same Industry, the average monthly price growth was -0%, and the average quarterly price growth was -7%. SNYR experienced the highest price growth at 16%, while MEPDF experienced the biggest fall at -8%.

Volume

The average weekly volume growth across all stocks in the Medical Distributors Industry was 20%. For the same stocks of the Industry, the average monthly volume growth was 27% and the average quarterly volume growth was 147%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 61
Price Growth Rating: 59
SMR Rating: 100
Profit Risk Rating: 80
Seasonality Score: 0 (-100 ... +100)
View a ticker or compare two or three
COR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a real estate investment trust

Industry MedicalDistributors

Profile
Fundamentals
Details
Industry
Real Estate Investment Trusts
Address
1 West First Avenue
Phone
+1 610 727-7000
Employees
46000
Web
https://www.cencora.com